COFFMAN ROBERT, Senior Vice President, subtracted 32,218 shares of Dynavax Technologies Corporation (DVAX) from its portfolio at the rate of $4.58 per share valuing $147,687 on Jun 04. The insider left behind 77,768 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Dynavax Technologies Corporation (DVAX) was $3.83. Currently, the 1st Resistance Point for this stock is $3.90, with a 2nd Resistance Point sitting at $3.98. Meanwhile, this company’s stock has a 1st Support Level at $3.72 and a 2nd Support Level at $3.60. Dynavax Technologies Corporation (DVAX) stock has lost -$0.37, or -8.81%, in the past five days. In the last full month, these shares have lost -$3.16, or -45.21%. In the past three months, this stock’s price has fallen by -$4.59, or -54.51%. This year-to-date, Dynavax Technologies Corporation (DVAX) shares have lost -$5.32, or -58.14%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Dynavax Technologies Corporation (DVAX) stock, 80% of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, 100% of medium-term indicators point to this stock being a “ Sell .” Looking further ahead, 100% of long-term indicators suggest that this stock is a “ Sell .”
With 65,064 K shares outstanding, this company currently has a market capitalization of $242,038K. Dynavax Technologies Corporation (DVAX) generates $8,200 K in annual sales, amounting to annual net income of -$158,900 K. This stock has generated a 1-Year Total Return of -76.65%, a 3-Year Total Return of -73.16%, and a 5-year Total Return of -75.91%. This stock’s 5-Year Dividend Growth is 0.00%. Its Annual Dividend Yield is 0.00%, and its Annual Dividend Rate is 0.00.
For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is -$0.63 per share. This estimate came from a total of 2 Wall Street Analysts. Of those market experts, the high estimate was -$0.62 and the low estimate was -$0.65. In the year-ago quarter, Dynavax Technologies Corporation (DVAX) generated per-share earnings of -$0.63.
Turning our focus now to insider trading activity, there have been 7 purchases (286,222 shares in total) and 2 sale (54,702 shares in total) in the last 3 months. In the last 6 months, there have been 23 insider buys amounting to 613,827 shares and 20 insider sales amounting to 318,448 shares. In the past full year, 23 insider purchases were made (involving 613,827 shares) and 21 insider sell-offs equivalent to 320,448 shares.
Moving onto liquidity, Dynavax Technologies Corporation (DVAX) has a Current Ratio of 4.58, a Quick Ratio of 4.08 and a Cash Ratio of 3.83. Looking at this company’s capital structure, its Total Debt to Total Equity is 159.95, its Total Debt to Total Capital is 61.53, and its Total Debt to Total Assets is now 47.83. Looking even further ahead into the future, its Long-Term Debt to Equity is 159.95 and its Long-Term Debt to Total Capital is 61.53.